Literature DB >> 10577810

Effects of intranasal immunization on protective immunity against otitis media.

Y Kurono1, M Suzuki, G Mogi, M Yamamoto, K Fujihashi, J R McGhee, H Kiyono.   

Abstract

It has been reported that intranasal immunization can induce mucosal immune responses. However, the efficacy of intranasal immunization on otitis media caused by non-typeable Haemophilus influenzae (NTHi) is not yet elucidated. Mice were intranasally, orally, intratracheally or intraperitoneally immunized with outer membrane protein (OMP) isolated from NTHi, and antigen-specific immune responses were determined by enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immuno-spot assay (ELISPOT). Cytokine production from splenic CD4+ T cells was examined by ELISA. Following the immunization, the clearance of NTHi from the nasal and nasopharyngeal cavity was examined. OMP-specific IgA antibody titers in nasal washes and the numbers of specific IgA-producing cells in nasal passages were significantly increased in intranasally immunized mice. Cytokine analysis showed that interferon-gamma (IFN-gamma) and interleukins IL-6 and IL-10 were predominantly produced from CD4+ T cells. The clearance of NTHi was significantly enhanced in the intranasal immunization group. Intranasal immunization is an effective vaccination regimen for the induction of OMP-specific mucosal immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577810     DOI: 10.1016/s0165-5876(99)00165-2

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  5 in total

1.  Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.

Authors:  Sylvie Alonso; Eve Willery; Genevieve Renauld-Mongénie; Camille Locht
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate.

Authors:  Dai-Fang Liu; Kathryn W Mason; Maria Mastri; Mehran Pazirandeh; David Cutter; Doran L Fink; Joseph W St Geme; Duzhang Zhu; Bruce A Green
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

3.  Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein.

Authors:  Yuka Nomura; Yusuke Abe; Yoshiya Ishida; Hiroya Kobayashi; Yasuaki Harabuchi
Journal:  J Clin Immunol       Date:  2008-04-01       Impact factor: 8.317

Review 4.  The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion.

Authors:  Marina G Smirnova; John P Birchall; Jeffrey P Pearson
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

5.  Overexpression and Purification of C-terminal Fragment of the Passenger Domain of Hap Protein from Nontypeable Haemophilus influenzae in a Highly Optimized Escherichia coli Expression System.

Authors:  Akram Tabatabaee; Seyed Davar Siadat; Seyed Fazllolah Moosavi; Mohammad Reza Aghasadeghi; Arash Memarnejadian; Mohammad Hassan Pouriayevali; Neda Yavari
Journal:  Avicenna J Med Biotechnol       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.